An autonomous research institute under the Ministry of Finance

 

Study on Public Procurement of Pharmaceutical Drugs and Quality Control

Study on Public Procurement of Pharmaceutical Drugs and Quality Control

  • Start date जून, 2020
  • Completion date अप्रैल, 2021
  • Sponsor Thakur Family Foundation, Inc.
  • Project leader Ila Patnaik
  • Consultants/Other authors Harleen Kaur, Madhur Mehta, Ashim Kapoor and Siddharth Srivastava
  • Focus
    The objective of the study is to:
    􀀁 Research on Central and State government expenditure on public procurements; the procurement process evaluation; the tendering process;  blacklisting policies; how can India leverage the public procurement system to improve drug quality across the pharmaceutical industry; is there a need for public procurement law specific to procurement of drugs; profile of national companies which supply drugs to states; role of information about not of standard quality (NSQ) drugs published by the Central Drugs Standard Control Organisation (CDSCO) on Sugam portal in the procurement process; and what actions do agencies take on repeat offenders.
    􀀁 The study will produce two papers for the research study on public procurement by a representative cross-section of Central and state public  procurement agencies from a quality perspective.